Eleonora G. Dimitrova

Varna, Bulgaria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Genetic counseling for hereditary cancer syndromes: a 5-year experience from a single center in Bulgaria.

Genetic counseling for hereditary cancer syndromes: a 5-year experience from a single center in Bulgaria.

Journal: Oncology reviews
Published: April 03, 2025

Ethical and Psychosocial Issues Associated with Genetic Testing for Hereditary Tumor Predisposition Syndromes.

Ethical and Psychosocial Issues Associated with Genetic Testing for Hereditary Tumor Predisposition Syndromes.

Journal: Healthcare (Basel, Switzerland)
Published: March 11, 2025

A pictorial view on false positive findings of 68Ga-PSMA-11 PET/CT and their prognostic value in patients with prostate carcinoma after radical prostatectomy and undetectable PSA values.

A pictorial view on false positive findings of 68Ga-PSMA-11 PET/CT and their prognostic value in patients with prostate carcinoma after radical prostatectomy and undetectable PSA values.

Journal: Hellenic journal of nuclear medicine
Published: April 04, 2024

Prevalence and prognosis of PIK3CA mutations in Bulgarian patients with metastatic breast cancer receiving endocrine therapy in first-line setting.

Prevalence and prognosis of PIK3CA mutations in Bulgarian patients with metastatic breast cancer receiving endocrine therapy in first-line setting.

Journal: Cancer reports (Hoboken, N.J.)
Published: August 02, 2023

KRAS Mutation Status in Bulgarian Patients with Advanced and Metastatic Colorectal Cancer.

KRAS Mutation Status in Bulgarian Patients with Advanced and Metastatic Colorectal Cancer.

Journal: International journal of molecular sciences
Published: July 04, 2023

Infrarenal abdominal aortic dissection with aberrant renal arteries and lead-ing symptom right leg ischemia: case report.

Infrarenal abdominal aortic dissection with aberrant renal arteries and lead-ing symptom right leg ischemia: case report.

Journal: Hippokratia
Published: August 04, 2020

Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancer.

Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancer.

Journal: Clinical and experimental immunology
Published: April 24, 2020

Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancer.

Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancer.

Journal: Bioscience trends
Published: February 06, 2020

RIPK3 expression as a potential predictive and prognostic marker in metastatic colon cancer.

RIPK3 expression as a potential predictive and prognostic marker in metastatic colon cancer.

Journal: Clinical and investigative medicine. Medecine clinique et experimentale
Published: March 23, 2019

Association Between Serum CK-18 Levels and the Degree of Liver Damage in Fructose-Induced Metabolic Syndrome.

Association Between Serum CK-18 Levels and the Degree of Liver Damage in Fructose-Induced Metabolic Syndrome.

Journal: Metabolic syndrome and related disorders
Published: July 11, 2018

Role of the pretreatment 18F-fluorodeoxyglucose positron emission tomography maximal standardized uptake value in predicting outcomes of colon liver metastases and that value's association with Beclin-1 expression.

Role of the pretreatment 18F-fluorodeoxyglucose positron emission tomography maximal standardized uptake value in predicting outcomes of colon liver metastases and that value's association with Beclin-1 expression.

Journal: Bioscience trends
Published: March 03, 2017
Showing 1-11 of 11

Last Updated: 09/26/2026